NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
NAVCO Pharmaceuticals Inc. has partnered with SOF Marketing on a $300,000 CAD initiative aimed at enhancing investor relations through a comprehensive online marketing strategy. The campaign, running until October 12, 2024, includes rebranding, social media marketing, and targeted AdWords advertising. NAVCO specializes in nanotechnology for developing innovative products to combat various pathogens, serving markets in human health, household products, and veterinary care.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.